Abbott Laboratories (ABT) |
|
100.92 -1.81 (-1.76%)
|
09-25 08:44 |
|
Open: |
102.75 |
Pre. Close: |
102.73 |
|
High:
|
103.53 |
Low:
|
100.47 |
|
Volume:
|
7,408,356 |
Market Cap:
|
178,682M |
|
|
|
|
Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. The company is headquartered in Abbott Park, Illinois and currently employs 103,000 full-time employees. The firm operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products and Vascular Products. Its Established Pharmaceutical Products include a range of branded generic pharmaceuticals manufactured around the world and marketed and sold outside the United States. Its Diagnostic Products include a range of diagnostic systems and tests. Its Nutritional Products include a range of pediatric and adult nutritional products. Its Company's Vascular Products include a range of coronary, endovascular, vessel closure and structural heart devices for the treatment of vascular disease. The Company, through St. Jude Medical, Inc., also offers products, such as rhythm management products, electrophysiology products, heart failure related products, vascular products, structural heart products and neuromodulation products. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
103.685 - 104.41 |
104.41 - 104.966 |
|
Low:
|
98.584 - 99.562 |
99.562 - 100.312 |
|
Close:
|
99.565 - 100.881 |
100.881 - 101.892 |
|
Technical analysis |
as of: 2020-09-24 4:26:10 PM |
|
Overall:
|
 |
| Stoxline posted a SELL today, same as yesterday. Downward movement continues. |
| Target: |
Six months: 126.94 One year: 133.39 |
| Support: |
Support1: 99.75 Support2: 82.99 |
| Resistance: |
Resistance1: 108.68 Resistance2: 114.20 |
| Pivot: |
104.86  |
| Moving Average: |
MA(5): 104.25 MA(20): 106.02
MA(100): 97.10  MA(250): 89.53 |
| MACD: |
MACD(12,26): 0.32 Signal(9): 1.04 |
| Stochastic oscillator: |
%K(14,3): 14.49 %D(3): 25.22 |
| RSI: |
RSI(14): 41.37 |
| 52-week: |
High: 114.20 Low: 61.61 Change(%): 23.3 |
| Average Vol(K): |
3-Month: 520427 10-Days: 474608 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.ABT has closed below the lower band by 10.8%. If price is in a downtrend band; this downward trend in price might continue. However a short term pullback inside the band is likely. Bollinger Bands are 18.8% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Headline News |
Wed, 23 Sep 2020
Here's Our Rant About Abbott Laboratories (ABT) - The News Heater
Tue, 22 Sep 2020
Abbott Laboratories [ABT] gain 21.98% so far this year. What now? - The DBT News
Tue, 22 Sep 2020
Abbott Wins European Approval for Latest MitraClip Heart Valve Device - Motley Fool
Fri, 18 Sep 2020
Abbott Laboratories Stock Review (ABT): What You Need To Know - Pulse 2.0
Wed, 16 Sep 2020
ABT: Should You 'Buy the Dip' in Abbott Laboratories? - StockNews.com
Sun, 06 Sep 2020
Is Abbott Laboratories Stock a Buy? - The Motley Fool
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
 |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
|
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
 |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Price to Book Value: |
Outperform |
Discounted cash flow: |
Outperform |
| Return on Assets: |
Neutral |
Price to Earnings: |
Outperform |
| Return on Equity: |
Neutral |
Debt to Equity: |
Outperform |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NYSE |
| Sector: Healthcare |
| Industry: Medical Devices |
| Shares Out. (M) |
1,770 |
| Shares Float (M) |
1,760 |
|
% Held by Insiders
|
0.73 |
|
% Held by Institutions
|
77.18 |
|
Shares Short (K)
|
10,400 |
|
Shares Short P. Month (K)
|
12,710 |
Stock Financials |
|
EPS
|
1.730 |
|
EPS Est This Year
|
2.500 |
|
EPS Est Next Year
|
2.820 |
|
Book Value (p.s.)
|
17.270 |
|
Profit Margin
|
9.89 |
|
Operating Margin
|
14.00 |
|
Return on Assets (ttm)
|
4.0 |
|
Return on Equity (ttm)
|
9.9 |
|
Qtrly Rev. Growth
|
-8.2 |
|
Gross Profit (p.s.)
|
10.571 |
|
Sales Per Share
|
17.763 |
|
EBITDA (p.s.)
|
4.277 |
|
Qtrly Earnings Growth
|
-46.60 |
|
Operating Cash Flow (M)
|
6,400 |
|
Levered Free Cash Flow (M)
|
4,680 |
Stock Valuations |
|
PE Ratio
|
58.33 |
|
PEG Ratio
|
3.51 |
|
Price to Book value
|
5.84 |
|
Price to Sales
|
5.68 |
|
Price to Cash Flow
|
27.91 |
Stock Dividends |
|
Dividend
|
1.400 |
|
Forward Dividend
|
1.440 |
|
Dividend Yield
|
0.01 |
|
Dividend Pay Date
|
2020-08-16 |
|
Ex-Dividend Date
|
2020-07-13 |
|
7 Binary Options
|
|
Your Ad Here
|
|
